000 03352nam a22003975i 4500
001 293237
003 MX-SnUAN
005 20160429155058.0
007 cr nn 008mamaa
008 150903s2014 sz | o |||| 0|eng d
020 _a9783034807067
_99783034807067
024 7 _a10.1007/9783034807067
_2doi
035 _avtls000345375
039 9 _a201509030412
_bVLOAD
_c201405050320
_dVLOAD
_y201402061335
_zstaff
040 _aMX-SnUAN
_bspa
_cMX-SnUAN
_erda
050 4 _aRM1-950
100 1 _aBosch, Xavier.
_eeditor.
_9325680
245 1 0 _aDrugs Targeting B-Cells in Autoimmune Diseases /
_cedited by Xavier Bosch, Manuel Ramos-Casals, Munther A Khamashta.
264 1 _aBasel :
_bSpringer Basel :
_bImprint: Springer,
_c2014.
300 _axI, 292 páginas 3 ilustraciones, 2 ilustraciones en color.
_brecurso en línea.
336 _atexto
_btxt
_2rdacontent
337 _acomputadora
_bc
_2rdamedia
338 _arecurso en línea
_bcr
_2rdacarrier
347 _aarchivo de texto
_bPDF
_2rda
490 0 _aMilestones in Drug Therapy,
_x2296-6056
500 _aSpringer eBooks
505 0 _aHistoric outline of the development of drugs targeting B-cells -- Understanding B-cell biology -- Pharmacological effects and mechanisms of action of agents blocking B cells -- Systemic lupus erythematosus: direct B-cell blocking -- Systemic lupus erythematosus: indirect B-cell blocking -- B-cell targeted therapies in rheumatoid arthritis -- B-cell targeted therapies in Primary Sjögren Syndrome -- Targeting B cells in ANCA-associated vasculitis -- B-cell targeted therapies in systemic sclerosis and inflammatory myopathies -- B-cell targeted therapies in cryoglobulinemia -- B-cell targeted therapies in autoimmune cytopenias and thrombosis -- Targeting B cells in neurological autoimmune diseases -- Targeting B cells in other systemic autoimmune diseases -- Safety of B-cell targeted therapies -- The future potential of biosimilars targeting B-cells.
520 _aThis book provides a detailed overview of B-cell directed therapies in patients with rheumatic and systemic autoimmune diseases, including rheumatoid arthritis, systemic lupus erythematosus, Sjögren syndrome, ANCA-associated vasculitis and cryoglobulinemia. Organ-specific autoimmune diseases are discussed with respect to the use of B-cell directed therapies in neurological autoimmune diseases and autoimmune cytopenias. Situations in which B-cell targeted therapy may be indicated are identified, thereby offering comprehensive support for therapeutic decisions on the basis of the latest published evidence. The book also offers a valuable reference tool for rheumatologists, internists, nephrologists, immunologists, and all specialists involved in the multidisciplinary care of patients with rheumatic and systemic autoimmune diseases.
590 _aPara consulta fuera de la UANL se requiere clave de acceso remoto.
700 1 _aRamos-Casals, Manuel.
_eeditor.
_9305768
700 1 _aKhamashta, Munther A.
_eeditor.
_9305767
710 2 _aSpringerLink (Servicio en línea)
_9299170
776 0 8 _iEdición impresa:
_z9783034807050
856 4 0 _uhttp://remoto.dgb.uanl.mx/login?url=http://dx.doi.org/10.1007/978-3-0348-0706-7
_zConectar a Springer E-Books (Para consulta externa se requiere previa autentificación en Biblioteca Digital UANL)
942 _c14
999 _c293237
_d293237